ID   PGLT1_HUMAN             Reviewed;         392 AA.
AC   Q8NBL1; B2RD13; Q53GJ4; Q8N2T1;
DT   25-JUL-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   10-MAY-2017, entry version 130.
DE   RecName: Full=Protein O-glucosyltransferase 1 {ECO:0000305};
DE            EC=2.4.1.- {ECO:0000269|PubMed:21490058, ECO:0000269|PubMed:21949356};
DE   AltName: Full=CAP10-like 46 kDa protein {ECO:0000303|PubMed:16524674};
DE            Short=hCLP46 {ECO:0000303|PubMed:16524674};
DE   AltName: Full=KTEL motif-containing protein 1;
DE   AltName: Full=Myelodysplastic syndromes relative protein;
DE   AltName: Full=O-glucosyltransferase Rumi homolog {ECO:0000303|PubMed:21490058};
DE            Short=hRumi {ECO:0000303|PubMed:21490058};
DE   AltName: Full=Protein O-xylosyltransferase POGLUT1 {ECO:0000305};
DE            EC=2.4.2.26 {ECO:0000269|PubMed:21081508};
DE   Flags: Precursor;
GN   Name=POGLUT1 {ECO:0000312|HGNC:HGNC:22954};
GN   Synonyms=C3orf9 {ECO:0000312|HGNC:HGNC:22954},
GN   CLP46 {ECO:0000303|PubMed:16524674}, KTELC1, MDSRP;
GN   ORFNames=MDS010, UNQ490/PRO1006 {ECO:0000303|PubMed:12975309};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Hematopoietic stem cell;
RX   PubMed=16524674; DOI=10.1016/j.gene.2005.08.027;
RA   Teng Y., Liu Q., Ma J., Liu F., Han Z., Wang Y., Wang W.;
RT   "Cloning, expression and characterization of a novel human CAP10-like
RT   gene hCLP46 from CD34+ stem/progenitor cells.";
RL   Gene 371:7-15(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ARG-75 AND
RP   THR-229.
RC   TISSUE=Fetal brain, and Hypothalamus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 24-38.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF GLY-169.
RX   PubMed=21490058; DOI=10.1242/dev.060020;
RA   Fernandez-Valdivia R., Takeuchi H., Samarghandi A., Lopez M.,
RA   Leonardi J., Haltiwanger R.S., Jafar-Nejad H.;
RT   "Regulation of mammalian Notch signaling and embryonic development by
RT   the protein O-glucosyltransferase Rumi.";
RL   Development 138:1925-1934(2011).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=21081508; DOI=10.1093/glycob/cwq187;
RA   Wu Z.L., Ethen C.M., Prather B., Machacek M., Jiang W.;
RT   "Universal phosphatase-coupled glycosyltransferase assay.";
RL   Glycobiology 21:727-733(2011).
RN   [12]
RP   FUNCTION.
RX   PubMed=21949356; DOI=10.1073/pnas.1109696108;
RA   Takeuchi H., Fernandez-Valdivia R.C., Caswell D.S., Nita-Lazar A.,
RA   Rana N.A., Garner T.P., Weldeghiorghis T.K., Macnaughtan M.A.,
RA   Jafar-Nejad H., Haltiwanger R.S.;
RT   "Rumi functions as both a protein O-glucosyltransferase and a protein
RT   O-xylosyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:16600-16605(2011).
RN   [13]
RP   INVOLVEMENT IN DDD4, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24387993; DOI=10.1016/j.ajhg.2013.12.003;
RA   Basmanav F.B., Oprisoreanu A.M., Pasternack S.M., Thiele H., Fritz G.,
RA   Wenzel J., Grosser L., Wehner M., Wolf S., Fagerberg C., Bygum A.,
RA   Altmuller J., Rutten A., Parmentier L., El Shabrawi-Caelen L.,
RA   Hafner C., Nurnberg P., Kruse R., Schoch S., Hanneken S., Betz R.C.;
RT   "Mutations in POGLUT1, encoding protein O-glucosyltransferase 1, cause
RT   autosomal-dominant Dowling-Degos disease.";
RL   Am. J. Hum. Genet. 94:135-143(2014).
RN   [14]
RP   FUNCTION, SUBCELLULAR LOCATION, INVOLVEMENT IN LGMD2Z, VARIANT LGMD2Z
RP   GLU-233, AND CHARACTERIZATION OF VARIANT LGMD2Z GLU-233.
RX   PubMed=27807076; DOI=10.15252/emmm.201505815;
RA   Servian-Morilla E., Takeuchi H., Lee T.V., Clarimon J., Mavillard F.,
RA   Area-Gomez E., Rivas E., Nieto-Gonzalez J.L., Rivero M.C.,
RA   Cabrera-Serrano M., Gomez-Sanchez L., Martinez-Lopez J.A., Estrada B.,
RA   Marquez C., Morgado Y., Suarez-Calvet X., Pita G., Bigot A.,
RA   Gallardo E., Fernandez-Chacon R., Hirano M., Haltiwanger R.S.,
RA   Jafar-Nejad H., Paradas C.;
RT   "A POGLUT1 mutation causes a muscular dystrophy with reduced Notch
RT   signaling and satellite cell loss.";
RL   EMBO Mol. Med. 8:1289-1309(2016).
RN   [15]
RP   VARIANTS DDD4 GLU-170; 218-ARG--LEU-392 DEL AND TYR-286.
RX   PubMed=27479915; DOI=10.1111/bjd.14914;
RA   Wilson N.J., Cole C., Kroboth K., Hunter W.N., Mann J.A., McLean W.H.,
RA   Kernland Lang K., Beltraminelli H., Sabroe R.A., Tiffin N.,
RA   Sobey G.J., Borradori L., Simpson E., Smith F.J.;
RT   "Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.";
RL   Br. J. Dermatol. 176:270-274(2017).
CC   -!- FUNCTION: Dual specificity glycosyltransferase that catalyzes the
CC       transfer of glucose and xylose from UDP-glucose and UDP-xylose,
CC       respectively, to a serine residue found in the consensus sequence
CC       of C-X-S-X-P-C (PubMed:21081508, PubMed:21490058, PubMed:21949356,
CC       PubMed:27807076). Specifically targets extracellular EGF repeats
CC       of protein such as CRB2, F7, F9 and NOTCH2 (PubMed:21081508,
CC       PubMed:21490058, PubMed:21949356, PubMed:27807076). Acts as a
CC       positive regulator of Notch signaling by mediating O-glucosylation
CC       of Notch, leading to regulate muscle development
CC       (PubMed:27807076). Notch glucosylation does not affect Notch
CC       ligand binding (PubMed:21490058). Required during early
CC       development to promote gastrulation: acts by mediating O-
CC       glucosylation of CRB2, which is required for CRB2 localization to
CC       the cell membrane (By similarity). {ECO:0000250|UniProtKB:Q8BYB9,
CC       ECO:0000269|PubMed:21081508, ECO:0000269|PubMed:21490058,
CC       ECO:0000269|PubMed:21949356, ECO:0000269|PubMed:27807076}.
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-xylose + [protein]-L-serine = UDP
CC       + [protein]-3-O-(beta-D-xylosyl)-L-serine.
CC       {ECO:0000269|PubMed:21081508}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=72 uM for UDP-Glc {ECO:0000269|PubMed:21081508};
CC         Vmax=7.6 pmol/min/ug enzyme {ECO:0000269|PubMed:21081508};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000269|PubMed:21081508, ECO:0000269|PubMed:21490058,
CC       ECO:0000269|PubMed:21949356}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000269|PubMed:16524674, ECO:0000269|PubMed:24387993,
CC       ECO:0000269|PubMed:27807076}.
CC   -!- TISSUE SPECIFICITY: Expressed in most adult tissues at different
CC       intensities. Abundantly expressed in liver. Expressed also in
CC       brain, heart, skeletal muscle, spleen, kidney, placenta, lung and
CC       peripheral blood leukocyte. Not detectable in colon, thymus and
CC       small intestine. Expressed in the epidermis, especially in the
CC       upper parts, stratum spinosum and stratum granulosum (at protein
CC       level). {ECO:0000269|PubMed:16524674,
CC       ECO:0000269|PubMed:24387993}.
CC   -!- DISEASE: Dowling-Degos disease 4 (DDD4) [MIM:615696]: A form of
CC       Dowling-Degos disease, a genodermatosis manifesting with
CC       postpubertal reticulate hyperpigmentation that is progressive and
CC       disfiguring, and small hyperkeratotic dark brown papules that
CC       affect mainly the flexures and great skin folds. Patients usually
CC       show no abnormalities of the hair or nails. DDD4 is characterized
CC       by prominent involvement of non-flexural skin areas.
CC       {ECO:0000269|PubMed:24387993, ECO:0000269|PubMed:27479915}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Limb-girdle muscular dystrophy 2Z (LGMD2Z) [MIM:617232]:
CC       A form of autosomal recessive limb-girdle muscular dystrophy, a
CC       degenerative myopathy characterized by slowly progressive wasting
CC       and weakness of the proximal muscles of arms and legs around the
CC       pelvic or shoulder girdles, elevated creatine kinase levels and
CC       dystrophic features on muscle biopsy. LGMD2Z is characterized by
CC       young-adult onset. {ECO:0000269|PubMed:27807076}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 90 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY298903; AAP56253.1; -; mRNA.
DR   EMBL; AY358581; AAQ88944.1; -; mRNA.
DR   EMBL; AK075444; BAC11625.1; -; mRNA.
DR   EMBL; AK222937; BAD96657.1; -; mRNA.
DR   EMBL; AK315367; BAG37760.1; -; mRNA.
DR   EMBL; AC074271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC073352; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79570.1; -; Genomic_DNA.
DR   EMBL; BC030614; AAH30614.1; -; mRNA.
DR   EMBL; BC048810; AAH48810.1; -; mRNA.
DR   CCDS; CCDS2988.1; -.
DR   RefSeq; NP_689518.1; NM_152305.2.
DR   UniGene; Hs.231750; -.
DR   ProteinModelPortal; Q8NBL1; -.
DR   SMR; Q8NBL1; -.
DR   BioGrid; 121300; 27.
DR   STRING; 9606.ENSP00000295588; -.
DR   CAZy; GT90; Glycosyltransferase Family 90.
DR   iPTMnet; Q8NBL1; -.
DR   PhosphoSitePlus; Q8NBL1; -.
DR   BioMuta; POGLUT1; -.
DR   DMDM; 74730148; -.
DR   EPD; Q8NBL1; -.
DR   MaxQB; Q8NBL1; -.
DR   PaxDb; Q8NBL1; -.
DR   PeptideAtlas; Q8NBL1; -.
DR   PRIDE; Q8NBL1; -.
DR   DNASU; 56983; -.
DR   Ensembl; ENST00000295588; ENSP00000295588; ENSG00000163389.
DR   GeneID; 56983; -.
DR   KEGG; hsa:56983; -.
DR   UCSC; uc003ecm.4; human.
DR   CTD; 56983; -.
DR   DisGeNET; 56983; -.
DR   GeneCards; POGLUT1; -.
DR   HGNC; HGNC:22954; POGLUT1.
DR   HPA; HPA037855; -.
DR   MalaCards; POGLUT1; -.
DR   MIM; 615618; gene.
DR   MIM; 615696; phenotype.
DR   MIM; 617232; phenotype.
DR   neXtProt; NX_Q8NBL1; -.
DR   OpenTargets; ENSG00000163389; -.
DR   Orphanet; 79145; Dowling-Degos disease.
DR   PharmGKB; PA162393771; -.
DR   eggNOG; KOG2458; Eukaryota.
DR   eggNOG; ENOG410XT5U; LUCA.
DR   GeneTree; ENSGT00530000063132; -.
DR   HOVERGEN; HBG069044; -.
DR   InParanoid; Q8NBL1; -.
DR   KO; K13667; -.
DR   OMA; INHLQMD; -.
DR   OrthoDB; EOG091G0BPU; -.
DR   PhylomeDB; Q8NBL1; -.
DR   TreeFam; TF323280; -.
DR   Reactome; R-HSA-1912399; Pre-NOTCH Processing in the Endoplasmic Reticulum.
DR   SIGNOR; Q8NBL1; -.
DR   UniPathway; UPA00378; -.
DR   GenomeRNAi; 56983; -.
DR   PRO; PR:Q8NBL1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000163389; -.
DR   CleanEx; HS_KTELC1; -.
DR   ExpressionAtlas; Q8NBL1; baseline and differential.
DR   Genevisible; Q8NBL1; HS.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0046527; F:glucosyltransferase activity; IDA:MGI.
DR   GO; GO:0030158; F:protein xylosyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0035251; F:UDP-glucosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0035252; F:UDP-xylosyltransferase activity; IMP:UniProtKB.
DR   GO; GO:0048318; P:axial mesoderm development; IEA:Ensembl.
DR   GO; GO:0072358; P:cardiovascular system development; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:UniProtKB-KW.
DR   GO; GO:0006664; P:glycolipid metabolic process; IBA:GO_Central.
DR   GO; GO:0060537; P:muscle tissue development; IMP:UniProtKB.
DR   GO; GO:0048339; P:paraxial mesoderm development; IEA:Ensembl.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006493; P:protein O-linked glycosylation; IDA:MGI.
DR   GO; GO:0018242; P:protein O-linked glycosylation via serine; IMP:UniProtKB.
DR   GO; GO:0010470; P:regulation of gastrulation; ISS:UniProtKB.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   InterPro; IPR006598; LipoPS_modifying.
DR   Pfam; PF05686; Glyco_transf_90; 1.
DR   SMART; SM00672; CAP10; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Developmental protein; Direct protein sequencing;
KW   Disease mutation; Endoplasmic reticulum; Gastrulation; Glycoprotein;
KW   Glycosyltransferase; Limb-girdle muscular dystrophy; Polymorphism;
KW   Reference proteome; Signal; Transferase.
FT   SIGNAL        1     23       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        24    392       Protein O-glucosyltransferase 1.
FT                                /FTId=PRO_0000246685.
FT   MOTIF       389    392       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   CARBOHYD     40     40       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    204    204       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    373    373       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      75     75       K -> R (in dbSNP:rs11556605).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027041.
FT   VARIANT     170    170       G -> E (in DDD4).
FT                                {ECO:0000269|PubMed:27479915}.
FT                                /FTId=VAR_077954.
FT   VARIANT     218    392       Missing (in DDD4).
FT                                {ECO:0000269|PubMed:27479915}.
FT                                /FTId=VAR_077955.
FT   VARIANT     229    229       P -> T (in dbSNP:rs17852785).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_027042.
FT   VARIANT     233    233       D -> E (in LGMD2Z; reduced
FT                                glucosyltransferase and
FT                                xylosyltransferase activities; impaired
FT                                Notch signaling).
FT                                {ECO:0000269|PubMed:27807076}.
FT                                /FTId=VAR_077956.
FT   VARIANT     286    286       C -> Y (in DDD4).
FT                                {ECO:0000269|PubMed:27479915}.
FT                                /FTId=VAR_077957.
FT   MUTAGEN     169    169       G->E: Loss of O-glucosyltransferase
FT                                activity. {ECO:0000269|PubMed:21490058}.
FT   CONFLICT    287    287       G -> D (in Ref. 5; BAD96657).
FT                                {ECO:0000305}.
FT   CONFLICT    371    371       S -> P (in Ref. 5; BAD96657).
FT                                {ECO:0000305}.
SQ   SEQUENCE   392 AA;  46189 MW;  25B0370757A6B224 CRC64;
     MEWWASSPLR LWLLLFLLPS AQGRQKESGS KWKVFIDQIN RSLENYEPCS SQNCSCYHGV
     IEEDLTPFRG GISRKMMAEV VRRKLGTHYQ ITKNRLYREN DCMFPSRCSG VEHFILEVIG
     RLPDMEMVIN VRDYPQVPKW MEPAIPVFSF SKTSEYHDIM YPAWTFWEGG PAVWPIYPTG
     LGRWDLFRED LVRSAAQWPW KKKNSTAYFR GSRTSPERDP LILLSRKNPK LVDAEYTKNQ
     AWKSMKDTLG KPAAKDVHLV DHCKYKYLFN FRGVAASFRF KHLFLCGSLV FHVGDEWLEF
     FYPQLKPWVH YIPVKTDLSN VQELLQFVKA NDDVAQEIAE RGSQFIRNHL QMDDITCYWE
     NLLSEYSKFL SYNVTRRKGY DQIIPKMLKT EL
//
